人类血浆蛋白质组遗传决定因素的祖先多样性和相关的新药物靶点

Saredo Said, Alfred Pozarickij, Kuang Lin, Sam Morris, Christiana Kartsonaki, Neil Wright, Hannah Fry, Yiping Chen, Huaidong Du, Derrick Bennett, Daniel Avery, Dan Valle Schmidt, Liming Li, Jun Lv, Canqing Yu, Dianjianyi Sun, Pei Pei, Junshi Chen, Michael Hill, Richard Peto, Rory Collins, Robert Clarke, Iona Millwood, Zhengming Chen, Robin Walters
{"title":"人类血浆蛋白质组遗传决定因素的祖先多样性和相关的新药物靶点","authors":"Saredo Said, Alfred Pozarickij, Kuang Lin, Sam Morris, Christiana Kartsonaki, Neil Wright, Hannah Fry, Yiping Chen, Huaidong Du, Derrick Bennett, Daniel Avery, Dan Valle Schmidt, Liming Li, Jun Lv, Canqing Yu, Dianjianyi Sun, Pei Pei, Junshi Chen, Michael Hill, Richard Peto, Rory Collins, Robert Clarke, Iona Millwood, Zhengming Chen, Robin Walters","doi":"10.1101/2023.11.13.23298365","DOIUrl":null,"url":null,"abstract":"The proteome is fundamental to human biology and disease but little is known about ancestral diversity of its genetic determinants. In GWAS of plasma levels of 1,451 proteins in 3,974 Chinese adults, we identified pQTLs for 1,082 proteins, including 743 with at least one cis-pQTL. Fine-mapping defined credible sets for 3,336 independent pQTLs, of which 31% did not overlap with corresponding analyses in European adults. We assessed 777 sentinel cis-pQTLs in phenome-wide MR analyses using GWAS Catalog and identified Bonferroni-significant associations for 22 protein-disease pairs. Among 10 protein-disease pairs identified from East Asian-specific GWAS, four had evidence of colocalisation. Evaluation of current drug development confirmed indications for one protein target, identified potential repurposing for seven, and discovered nine potential novel targets, including GP2 for Type-2-diabetes. The findings demonstrate the importance of extending genome-wide plasma proteomic analyses to non-European ancestry populations to identify potential novel drug targets for major diseases.","PeriodicalId":478577,"journal":{"name":"medRxiv (Cold Spring Harbor Laboratory)","volume":"64 24","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ancestry diversity in the genetic determinants of the human plasma proteome and associated new drug targets\",\"authors\":\"Saredo Said, Alfred Pozarickij, Kuang Lin, Sam Morris, Christiana Kartsonaki, Neil Wright, Hannah Fry, Yiping Chen, Huaidong Du, Derrick Bennett, Daniel Avery, Dan Valle Schmidt, Liming Li, Jun Lv, Canqing Yu, Dianjianyi Sun, Pei Pei, Junshi Chen, Michael Hill, Richard Peto, Rory Collins, Robert Clarke, Iona Millwood, Zhengming Chen, Robin Walters\",\"doi\":\"10.1101/2023.11.13.23298365\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The proteome is fundamental to human biology and disease but little is known about ancestral diversity of its genetic determinants. In GWAS of plasma levels of 1,451 proteins in 3,974 Chinese adults, we identified pQTLs for 1,082 proteins, including 743 with at least one cis-pQTL. Fine-mapping defined credible sets for 3,336 independent pQTLs, of which 31% did not overlap with corresponding analyses in European adults. We assessed 777 sentinel cis-pQTLs in phenome-wide MR analyses using GWAS Catalog and identified Bonferroni-significant associations for 22 protein-disease pairs. Among 10 protein-disease pairs identified from East Asian-specific GWAS, four had evidence of colocalisation. Evaluation of current drug development confirmed indications for one protein target, identified potential repurposing for seven, and discovered nine potential novel targets, including GP2 for Type-2-diabetes. The findings demonstrate the importance of extending genome-wide plasma proteomic analyses to non-European ancestry populations to identify potential novel drug targets for major diseases.\",\"PeriodicalId\":478577,\"journal\":{\"name\":\"medRxiv (Cold Spring Harbor Laboratory)\",\"volume\":\"64 24\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv (Cold Spring Harbor Laboratory)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2023.11.13.23298365\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv (Cold Spring Harbor Laboratory)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2023.11.13.23298365","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

蛋白质组是人类生物学和疾病的基础,但对其遗传决定因素的祖先多样性知之甚少。在3974名中国成年人的1451种蛋白质血浆水平的GWAS中,我们鉴定了1082种蛋白质的pqtl,其中743种至少具有一个顺式pqtl。精细映射定义了3336个独立pqtl的可信集,其中31%与欧洲成年人的相应分析不重叠。我们使用GWAS目录在全现象MR分析中评估了777个前点顺式pqtl,并鉴定了22个蛋白质-疾病对的bonferroni显著关联。在东亚特异性GWAS鉴定的10对蛋白质疾病对中,有4对有共定位的证据。目前的药物开发评估确认了1个蛋白靶点的适应症,确定了7个蛋白靶点的潜在再利用,并发现了9个潜在的新靶点,包括治疗2型糖尿病的GP2。这些发现证明了将全基因组血浆蛋白质组学分析扩展到非欧洲血统人群,以确定主要疾病的潜在新药物靶点的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Ancestry diversity in the genetic determinants of the human plasma proteome and associated new drug targets
The proteome is fundamental to human biology and disease but little is known about ancestral diversity of its genetic determinants. In GWAS of plasma levels of 1,451 proteins in 3,974 Chinese adults, we identified pQTLs for 1,082 proteins, including 743 with at least one cis-pQTL. Fine-mapping defined credible sets for 3,336 independent pQTLs, of which 31% did not overlap with corresponding analyses in European adults. We assessed 777 sentinel cis-pQTLs in phenome-wide MR analyses using GWAS Catalog and identified Bonferroni-significant associations for 22 protein-disease pairs. Among 10 protein-disease pairs identified from East Asian-specific GWAS, four had evidence of colocalisation. Evaluation of current drug development confirmed indications for one protein target, identified potential repurposing for seven, and discovered nine potential novel targets, including GP2 for Type-2-diabetes. The findings demonstrate the importance of extending genome-wide plasma proteomic analyses to non-European ancestry populations to identify potential novel drug targets for major diseases.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信